Related references
Note: Only part of the references are listed.CD40-targeted dendritic cell delivery of PLGA-nanoparticle vaccines induce potent anti-tumor responses
Rodney A. Rosalia et al.
BIOMATERIALS (2015)
Nanovaccine loaded with poly I:C and STAT3 siRNA robustly elicits anti-tumor immune responses through modulating tumor-associated dendritic cells in vivo
Zichao Luo et al.
BIOMATERIALS (2015)
Cancer Statistics, 2015
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2015)
Infection-mimicking poly(γ-glutamic acid) as adjuvant material for effective anti-tumor immune response
Anushree Seth et al.
INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES (2015)
Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer
Christina Twyman-Saint Victor et al.
NATURE (2015)
Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice
Matthias Obenaus et al.
NATURE BIOTECHNOLOGY (2015)
Immunomodulatory spherical nucleic acids
Aleksandar F. Radovic-Moreno et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Biodegradable Nanoellipsoidal Artificial Antigen Presenting Cells for Antigen Specific T-Cell Activation
Randall A. Meyer et al.
SMALL (2015)
In vivo Gold Nanoparticle Delivery of Peptide Vaccine Induces Anti-Tumor Immune Response in Prophylactic and Therapeutic Tumor Models
Joao Paulo Mattos Almeida et al.
SMALL (2015)
Nanoparticle-Delivered Transforming Growth Factor-β siRNA Enhances Vaccination against Advanced Melanoma by Modifying Tumor Microenvironment
Zhenghong Xu et al.
ACS NANO (2014)
Magnetic Field-Induced T Cell Receptor Clustering by Nanoparticles Enhances T Cell Activation and Stimulates Antitumor Activity
Karlo Perica et al.
ACS NANO (2014)
Final report of the phase I/II clinical trial of the E75 (nelipepimut-S) vaccine with booster inoculations to prevent disease recurrence in high-risk breast cancer patients
E. A. Mittendorf et al.
ANNALS OF ONCOLOGY (2014)
Programmed nanoparticles for combined immunomodulation, antigen presentation and tracking of immunotherapeutic cells
Min Beom Heo et al.
BIOMATERIALS (2014)
Targeting the tumor-draining lymph node with adjuvanted nanoparticles reshapes the anti-tumor immune response
Susan N. Thomas et al.
BIOMATERIALS (2014)
Cancer Treatment and Survivorship Statistics, 2014
Carol E. DeSantis et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Cancer Statistics, 2014
Rebecca Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2014)
Vaccination therapy for non-small-cell lung cancer
Kristof Cuppens et al.
CURRENT OPINION IN ONCOLOGY (2014)
Magnetic mesoporous silica nanoparticles for potential delivery of chemotherapeutic drugs and hyperthermia
Cuilian Tao et al.
DALTON TRANSACTIONS (2014)
The HER2 peptide nelipepimut-S (E75) vaccine (NeuVax™) in breast cancer patients at risk for recurrence: correlation of immunologic data with clinical response
Erika J. Schneble et al.
IMMUNOTHERAPY (2014)
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial
Charles Butts et al.
LANCET ONCOLOGY (2014)
Cancer Cell Membrane-Coated Nanoparticles for Anticancer Vaccination and Drug Delivery
Ronnie H. Fang et al.
NANO LETTERS (2014)
Combinational delivery of lipid-enveloped polymeric nanoparticles carrying different peptides for anti-tumor immunotherapy
Songwei Tan et al.
NANOMEDICINE (2014)
Therapeutic vaccines for cancer: an overview of clinical trials
Ignacio Melero et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2014)
Enhancing immunomodulation on innate immunity by shape transition among RNA triangle, square and pentagon nanovehicles
Emil F. Khisamutdinov et al.
NUCLEIC ACIDS RESEARCH (2014)
Induction of Antigen-Specific Immunity with a Vaccine Targeting NY-ESO-1 to the Dendritic Cell Receptor DEC-205
Madhav V. Dhodapkar et al.
SCIENCE TRANSLATIONAL MEDICINE (2014)
Adjuvant-carrying synthetic vaccine particles augment the immune response to encapsulated antigen and exhibit strong local immune activation without inducing systemic cytokine release
Petr O. Ilyinskii et al.
VACCINE (2014)
The right touch: design of artificial antigen-presenting cells to stimulate the immune system
Joep van der Weijden et al.
CHEMICAL SCIENCE (2014)
pH-Responsive Nanoparticle Vaccines for Dual-Delivery of Antigens and Immunostimulatory Oligonucleotides
John T. Wilson et al.
ACS NANO (2013)
Oncology Meets Immunology: The Cancer-Immunity Cycle
Daniel S. Chen et al.
IMMUNITY (2013)
Adjuvant MAGE-A3 Immunotherapy in Resected Non-Small-Cell Lung Cancer: Phase II Randomized Study Results
Johan Vansteenkiste et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Multifunctional nanoparticles co-delivering Trp2 peptide and CpG adjuvant induce potent cytotoxic T-lymphocyte response against melanoma and its lung metastasis
Zhenghong Xu et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Bioreducible alginate-poly(ethylenimine) nanogels as an antigen-delivery system robustly enhance vaccine-elicited humoral and cellular immune responses
Ping Li et al.
JOURNAL OF CONTROLLED RELEASE (2013)
Colocalized Delivery of Adjuvant and Antigen Using Nanolipoprotein Particles Enhances the Immune Response to Recombinant Antigens
Nicholas O. Fischer et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2013)
A Phase I vaccine trial using dendritic cells pulsed with autologous oxidized lysate for recurrent ovarian cancer
Lana E. Kandalaft et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Nanoengineering approaches to the design of artificial antigen-presenting cells
Joel C. Sunshine et al.
NANOMEDICINE (2013)
The big picture on nanomedicine: the state of investigational and approved nanomedicine products
Michael L. Etheridge et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2013)
Lipid-insertion enables targeting functionalization of erythrocyte membrane-cloaked nanoparticles
Ronnie H. Fang et al.
NANOSCALE (2013)
Gold Nanoparticle Delivery of Modified CpG Stimulates Macrophages and Inhibits Tumor Growth for Enhanced Immunotherapy
Adam Yuh Lin et al.
PLOS ONE (2013)
Nanoparticle conjugation of CpG enhances adjuvancy for cellular immunity and memory recall at low dose
Alexandre de Titta et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Cancer Nanomedicine: From Drug Delivery to Imaging
Edward Kai-Hua Chow et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
The endocytosis and intracellular fate of nanomedicines: Implication for rational design
Longfa Kou et al.
ASIAN JOURNAL OF PHARMACEUTICAL SCIENCES (2013)
Imageable Antigen-Presenting Gold Nanoparticle Vaccines for Effective Cancer Immunotherapy In Vivo
In-Hyun Lee et al.
ANGEWANDTE CHEMIE-INTERNATIONAL EDITION (2012)
Nanoparticle Delivery of Cancer Drugs
Andrew Z. Wang et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Increasing the efficacy of tumor cell vaccines by enhancing cross priming
Brian M. Andersen et al.
CANCER LETTERS (2012)
Exploiting the Mutanome for Tumor Vaccination
John C. Castle et al.
CANCER RESEARCH (2012)
Particle-mediated delivery of cytokines for immunotherapy
David A. Christian et al.
IMMUNOTHERAPY (2012)
Doxil® - The first FDA-approved nano-drug: Lessons learned
Yechezkel (Chezy) Barenholz
JOURNAL OF CONTROLLED RELEASE (2012)
Nanoparticles: a boon to drug delivery, therapeutics, diagnostics and imaging
Suphiya Parveen et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2012)
Combinatorial drug therapy for cancer in the post-genomic era
Bissan Al-Lazikani et al.
NATURE BIOTECHNOLOGY (2012)
Combination delivery of TGF-β inhibitor and IL-2 by nanoscale liposomal polymeric gels enhances tumour immunotherapy
Jason Park et al.
NATURE MATERIALS (2012)
Antibody-Antigen-Adjuvant Conjugates Enable Co-Delivery of Antigen and Adjuvant to Dendritic Cells in Cis but Only Have Partial Targeting Specificity
Martin Kreutz et al.
PLOS ONE (2012)
Development of Effective Cancer Vaccine Using Targeting System of Antigen Protein to APCs
Tomoaki Kurosaki et al.
PHARMACEUTICAL RESEARCH (2012)
Preclinical Development and Clinical Translation of a PSMA-Targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
Jeffrey Hrkach et al.
SCIENCE TRANSLATIONAL MEDICINE (2012)
Cellular Cancer Vaccines: an Update on the Development of Vaccines Generated from Cell Surface Antigens
Petr G. Lokhov et al.
Journal of Cancer (2012)
Adoptive immunotherapy for cancer: harnessing the T cell response
Nicholas P. Restifo et al.
NATURE REVIEWS IMMUNOLOGY (2012)
Cancer immunotherapy via dendritic cells
Karolina Palucka et al.
NATURE REVIEWS CANCER (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
Natural Innate and Adaptive Immunity to Cancer
Matthew D. Vesely et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 29 (2011)
Dimercaptosuccinic acid-coated magnetite nanoparticles for magnetically guided in vivo delivery of interferon gamma for cancer immunotherapy
Raquel Mejias et al.
BIOMATERIALS (2011)
Induction of anti-tumor cytotoxic T cell responses through PLGA-nanoparticle mediated antigen delivery
Zhiping Zhang et al.
BIOMATERIALS (2011)
Translating Tumor Antigens into Cancer Vaccines
Luigi Buonaguro et al.
CLINICAL AND VACCINE IMMUNOLOGY (2011)
Efficient In vivo Priming by Vaccination with Recombinant NY-ESO-1 Protein and CpG in Antigen Naive Prostate Cancer Patients
Julia Karbach et al.
CLINICAL CANCER RESEARCH (2011)
PROVENGE (Sipuleucel-T) in Prostate Cancer: The First FDA-Approved Therapeutic Cancer Vaccine
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2011)
Comparison of two CD40-ligand/interleukin-2 vaccines in patients with chronic lymphocytic leukemia
Fatma Visal Okur et al.
CYTOTHERAPY (2011)
CpG DNA as a vaccine adjuvant
Christian Bode et al.
EXPERT REVIEW OF VACCINES (2011)
Induction of CD8+ T-Cell Responses Against Novel Glioma-Associated Antigen Peptides and Clinical Activity by Vaccinations With α-Type 1 Polarized Dendritic Cells and Polyinosinic-Polycytidylic Acid Stabilized by Lysine and Carboxymethylcellulose in Patients With Recurrent Malignant Glioma
Hideho Okada et al.
JOURNAL OF CLINICAL ONCOLOGY (2011)
Effective Melanoma Immunotherapy with Interleukin-2 Delivered by a Novel Polymeric Nanoparticle
Hong Yao et al.
MOLECULAR CANCER THERAPEUTICS (2011)
Nanoparticle PEGylation for imaging and therapy
Jesse V. Jokerst et al.
NANOMEDICINE (2011)
Polymer nanoparticles containing tumor lysates as antigen delivery vehicles for dendritic cell-based antitumor immunotherapy
Shashi Prasad et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2011)
Cancer immunotherapy comes of age
Ira Mellman et al.
NATURE (2011)
Interbilayer-crosslinked multilamellar vesicles as synthetic vaccines for potent humoral and cellular immune responses
James J. Moon et al.
NATURE MATERIALS (2011)
Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
Haiyan Li et al.
NATURE NANOTECHNOLOGY (2011)
gp100 Peptide Vaccine and Interleukin-2 in Patients with Advanced Melanoma
Douglas J. Schwartzentruber et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Targeted antigen delivery and activation of dendritic cells in vivo: Steps towards cost effective vaccines
Paul J. Tacken et al.
SEMINARS IN IMMUNOLOGY (2011)
Co-encapsulation of antigen and Toll-like receptor ligand in cationic liposomes affects the quality of the immune response in mice after intradermal vaccination
Suzanne M. Bal et al.
VACCINE (2011)
Antigen shedding and metastasis of tumour cells
S. K. A. LAW
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Vaccination with autologous dendritic cells pulsed with multiple tumor antigens for treatment of patients with malignant melanoma: results from a phase I/II trial
Redas Trepiakas et al.
CYTOTHERAPY (2010)
Strategies for Cancer Vaccine Development
Matteo Vergati et al.
JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY (2010)
Design considerations for tumour-targeted nanoparticles
Hak Soo Choi et al.
NATURE NANOTECHNOLOGY (2010)
Sipuleucel-T Immunotherapy for Castration-Resistant Prostate Cancer.
Philip W. Kantoff et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Surface modification, functionalization and bioconjugation of colloidal inorganic nanoparticles
R. A. Sperling et al.
PHILOSOPHICAL TRANSACTIONS OF THE ROYAL SOCIETY A-MATHEMATICAL PHYSICAL AND ENGINEERING SCIENCES (2010)
Rate, molecular spectrum, and consequences of human mutation
Michael Lynch
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Adjuvants for cancer vaccines
Thomas W. Dubensky et al.
SEMINARS IN IMMUNOLOGY (2010)
Antigen delivery to dendritic cells by poly(propylene sulfide) nanoparticles with disulfide conjugated peptides: Cross-presentation and T cell activation
Sachiko Hirosue et al.
VACCINE (2010)
MAGRIT: The Largest-Ever Phase III Lung Cancer Trial Aims to Establish a Novel Tumor-Specific Approach to Therapy
Preeta Tyagi et al.
CLINICAL LUNG CANCER (2009)
Timed Sequential Treatment With Cyclophosphamide, Doxorubicin, and an Allogeneic Granulocyte-Macrophage Colony-Stimulating Factor-Secreting Breast Tumor Vaccine: A Chemotherapy Dose-Ranging Factorial Study of Safety and Immune Activation
Leisha A. Emens et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Immunotherapy for Prostate Cancer: Walk, Don't Run
Charles G. Drake
JOURNAL OF CLINICAL ONCOLOGY (2009)
Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation
Satwinder Kaur Singh et al.
MOLECULAR IMMUNOLOGY (2009)
Antitumor Activity of G3139 Lipid Nanoparticles (LNPs)
Xiaogang Pan et al.
MOLECULAR PHARMACEUTICS (2009)
Immunostimulatory properties and enhanced TNF-α mediated cellular immunity for tumor therapy by C60(OH)20 nanoparticles
Ying Liu et al.
NANOTECHNOLOGY (2009)
Development of amphiphilic γ-PGA-nanoparticle based tumor vaccine:: Potential of the nanoparticulate cytosolic protein delivery carrier
Tomoaki Yoshikawa et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2008)
Vaccination greatly reduces disease, disability, death and inequity worldwide
F. E. Andre et al.
BULLETIN OF THE WORLD HEALTH ORGANIZATION (2008)
Phase 1/2 dose-escalation study of a GM-CSF-Secreting, allogeneic, cellular immunotherapy for metastatic hormone-refractory prostate cancer
Celestial S. Higano et al.
CANCER (2008)
Allogeneic granulocyte macrophage colony-stimulating factor-secreting tumor immunotherapy alone or in sequence with cyclophosphamide for metastatic pancreatic cancer: A pilot study of safety, feasibility, and immune activation
Dan Laheru et al.
CLINICAL CANCER RESEARCH (2008)
Therapeutic nanoparticles for drug delivery in cancer
Kwangjae Cho et al.
CLINICAL CANCER RESEARCH (2008)
Systemic Cancer Treatment Related Side Effects: Are We Changing the Promethean Experience With Molecularly Targeted Therapies?
Carlo De Angelis
Current Oncology (2008)
Delivery of antigen using a novel mannosylated dendrimer potentiates immunogenicity in vitro and in vivo
Kuo-Ching Sheng et al.
EUROPEAN JOURNAL OF IMMUNOLOGY (2008)
Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery
Raquel Mejias et al.
JOURNAL OF CONTROLLED RELEASE (2008)
Enabling personalized cancer medicine through analysis of gene-expression patterns
Laura J. van 't Veer et al.
NATURE (2008)
Nanoparticle therapeutics: an emerging treatment modality for cancer
Mark E. Davis et al.
NATURE REVIEWS DRUG DISCOVERY (2008)
Tumor-inhibitory effect and immunomodulatory activity of fullerol C60(OH)x
Jiadan Zhu et al.
SMALL (2008)
Nanoparticles built by self-assembly of amphiphilic γ-PGA can deliver antigens to antigen-presenting cells with high efficiency:: A new tumor-vaccine carrier for eliciting effector T cells
Tomoaki Yoshikawa et al.
VACCINE (2008)
Co-delivery of cancer-associated antigen and Toll-like receptor 4 ligand in PLGA nanoparticles induces potent CD8+ T cell-mediated anti-tumor immunity
Samar Hamdy et al.
VACCINE (2008)
TLR ligands and antigen need to be coencapsulated into the same biodegradable microsphere for the generation of potent cytotoxic T lymphocyte responses
Eva Schlosser et al.
VACCINE (2008)
A simple but effective cancer vaccine consisting of an antigen and a cationic lipid
Weihsu Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2008)
Delivery by cationic gelatin nanoparticles strongly increases the immunostimulatory effects of CpG oligonucleotides
Klaus Zwiorek et al.
PHARMACEUTICAL RESEARCH (2008)
Paul Ehrlich's magic bullet concept: 100 years of progress
Klaus Strebhardt et al.
NATURE REVIEWS CANCER (2008)
Nanocarriers as an emerging platform for cancer therapy
Dan Peer et al.
NATURE NANOTECHNOLOGY (2007)
Exploiting lymphatic transport and complement activation in nanoparticle vaccines
Sai T. Reddy et al.
NATURE BIOTECHNOLOGY (2007)
Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN
Susan de Jong et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Protein direct delivery to dendritic cells using nanoparticles based on amphiphilic poly(amino acid) derivatives
Takami Akagi et al.
BIOMATERIALS (2007)
Adoptive T cell therapy for cancer in the clinic
Carl H. June
JOURNAL OF CLINICAL INVESTIGATION (2007)
Immune surveillance of tumors
Jeremy B. Swann et al.
JOURNAL OF CLINICAL INVESTIGATION (2007)
Cancer immunoediting from immune surveillance to immune escape
Ryungsa Kim et al.
IMMUNOLOGY (2007)
Pathogen-mimicking nanoparticles for vaccine delivery to dendritic cells
Praveen Elamanchili et al.
JOURNAL OF IMMUNOTHERAPY (2007)
Targeting of antigen to dendritic cells with poly(γ-glutamic acid) nanoparticles induces antigen-specific humoral and cellular immunity
Tomofumi Uto et al.
JOURNAL OF IMMUNOLOGY (2007)
Polymer nanoparticles for immunotherapy from encapsulated tumor-associated antigens and whole tumor cells
C. M. Solbrig et al.
MOLECULAR PHARMACEUTICS (2007)
Challenges for cancer vaccine development
Z. Tabi et al.
ADVANCED DRUG DELIVERY REVIEWS (2006)
Immunostimulation of dendritic cells by cationic liposomes
Dileep P. Vangasseri et al.
MOLECULAR MEMBRANE BIOLOGY (2006)
Abraxane®, a novel Cremophor®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
M. R. Green et al.
ANNALS OF ONCOLOGY (2006)
Placebo-controlled phase III trial of immunologic therapy with sipuleucel-T (APC8015) in patients with metastatic, asymptomatic hormone refractory prostate cancer
Eric J. Small et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
In vivo targeting of dendritic cells in lymph nodes with poly(propylene sulfide) nanoparticles
ST Reddy et al.
JOURNAL OF CONTROLLED RELEASE (2006)
Phase II Study of Lucanix™ a Transforming Growth Factor β2 (TGF-β2) Antisense Gene Modified Allogeneic Tumor Cell Vaccine in Non Small Cell Lung Cancer (NSCLC)
John Nemunaitis et al.
MOLECULAR THERAPY (2006)
Toll-dependent selection of microbial antigens for presentation by dendritic cells
JM Blander et al.
NATURE (2006)
Enhanced and prolonged cross-presentation following endosomal escape of exogenous antigens encapsulated in biodegradable nanoparticles
H Shen et al.
IMMUNOLOGY (2006)
Exploiting the enhanced permeability and retention effect for tumor targeting
Arun K. Iyer et al.
DRUG DISCOVERY TODAY (2006)
Tumor regression and autoimmunity in patients treated with cytotoxic T lymphocyte-associated antigen 4 blockade and interleukin 2: A phase I/II study
AV Maker et al.
ANNALS OF SURGICAL ONCOLOGY (2005)
Enhanced antigen presentation and immunostimulation of dendritic cells using acid-degradable cationic nanoparticles
YJ Kwon et al.
JOURNAL OF CONTROLLED RELEASE (2005)
Immunotherapy with autologous tumor cell-BCG vaccine in patients with colon cancer: a prospective study of medical and economic benefits
CA Uyl-de Groot et al.
VACCINE (2005)
Immunostimulation mechanism of LPD nanoparticle as a vaccine carrier
Zhengrong Cui et al.
MOLECULAR PHARMACEUTICS (2005)
Cancer immunotherapy: moving beyond current vaccines
SA Rosenberg et al.
NATURE MEDICINE (2004)
Downregulation and/or release of NKG2D ligands as immune evasion strategy of human neuroblastoma
L Raffaghello et al.
NEOPLASIA (2004)
Vaccination with tumor lysate-pulsed dendritic cells elicits antigen-specific, cytotoxic T-cells in patients with malignant glioma
JS Yu et al.
CANCER RESEARCH (2004)
Liposome-encapsulated CpG oligodeoxynucleotides as a potent adjuvant for inducing type 1 innate immunity
Y Suzuki et al.
CANCER RESEARCH (2004)
Cytokines in cancer pathogenesis and cancer therapy
G Dranoff
NATURE REVIEWS CANCER (2004)
Phase I and pharmacokinetic study of Genexol-PM, a cremophor-free, polymeric micelle-formulated paclitaxel, in patients with advanced malignancies
TY Kim et al.
CLINICAL CANCER RESEARCH (2004)
Coating of mannan on LPD particles containing HPV E7 peptide significantly enhances immunity against HPV-positive tumor
ZG Cui et al.
PHARMACEUTICAL RESEARCH (2004)
Recognition of pathogen-associated molecular patterns by TLR family
S Akira et al.
IMMUNOLOGY LETTERS (2003)
Paclitaxel-loaded PLGA nanoparticles: preparation, physicochemical characterization and in vitro anti-tumoral activity
C Fonseca et al.
JOURNAL OF CONTROLLED RELEASE (2002)
A significant enhancement of therapeutic effect against hepatic metastases of M5076 in mice by a liposomal interleukin-2 (mixture)
E Kanaoka et al.
JOURNAL OF CONTROLLED RELEASE (2002)
Adjuvant active specific immunotherapy of stage II and stage III colon cancer with an autologous tumor cell vaccine: first randomized phase III trials show promise
MG Hanna et al.
VACCINE (2001)
Share Paper
